BOLT
Price
$5.92
Change
+$0.01 (+0.17%)
Updated
Jul 3 closing price
Capitalization
11.35M
32 days until earnings call
ELVN
Price
$20.73
Change
+$0.09 (+0.44%)
Updated
Jul 3 closing price
Capitalization
1.22B
32 days until earnings call
Interact to see
Advertisement

BOLT vs ELVN

Header iconBOLT vs ELVN Comparison
Open Charts BOLT vs ELVNBanner chart's image
Bolt Biotherapeutics
Price$5.92
Change+$0.01 (+0.17%)
Volume$928
Capitalization11.35M
Enliven Therapeutics
Price$20.73
Change+$0.09 (+0.44%)
Volume$272.51K
Capitalization1.22B
BOLT vs ELVN Comparison Chart in %
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. ELVN commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Buy and ELVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BOLT: $5.92 vs. ELVN: $20.73)
Brand notoriety: BOLT and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 3% vs. ELVN: 52%
Market capitalization -- BOLT: $11.35M vs. ELVN: $1.22B
BOLT [@Biotechnology] is valued at $11.35M. ELVN’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than BOLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 5 bullish TA indicator(s).

  • BOLT’s TA Score: 5 bullish, 1 bearish.
  • ELVN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BOLT is a better buy in the short-term than ELVN.

Price Growth

BOLT (@Biotechnology) experienced а +2.96% price change this week, while ELVN (@Biotechnology) price change was -3.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BOLT is expected to report earnings on Aug 06, 2025.

ELVN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.22B) has a higher market cap than BOLT($11.3M). ELVN YTD gains are higher at: -7.867 vs. BOLT (-44.683). BOLT has higher annual earnings (EBITDA): -61.54M vs. ELVN (-109.95M). ELVN has more cash in the bank: 290M vs. BOLT (38.8M). ELVN has less debt than BOLT: ELVN (365K) vs BOLT (24.7M). BOLT has higher revenues than ELVN: BOLT (3.64M) vs ELVN (0).
BOLTELVNBOLT / ELVN
Capitalization11.3M1.22B1%
EBITDA-61.54M-109.95M56%
Gain YTD-44.683-7.867568%
P/E RatioN/AN/A-
Revenue3.64M0-
Total Cash38.8M290M13%
Total Debt24.7M365K6,767%
TECHNICAL ANALYSIS
Technical Analysis
BOLTELVN
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLSX51.070.66
+1.31%
Lord Abbett Growth Leaders R4
LGOPX26.070.31
+1.20%
Lord Abbett Growth Opportunities P
ARSKX72.470.58
+0.81%
Archer Stock
QFVRX12.730.04
+0.32%
Pear Tree Polaris Foreign Value R6
DEQAX14.29N/A
N/A
BNY Mellon Global Equity Income - A

BOLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLT has been loosely correlated with XENE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLT jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+0.17%
XENE - BOLT
39%
Loosely correlated
-0.33%
ATXS - BOLT
38%
Loosely correlated
+1.40%
ELVN - BOLT
35%
Loosely correlated
+0.44%
BHVN - BOLT
35%
Loosely correlated
-0.88%
RLYB - BOLT
34%
Loosely correlated
+0.73%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.44%
DNLI - ELVN
51%
Loosely correlated
-1.41%
ERAS - ELVN
50%
Loosely correlated
-0.69%
APGE - ELVN
48%
Loosely correlated
+7.08%
SYRE - ELVN
48%
Loosely correlated
+1.68%
NRIX - ELVN
46%
Loosely correlated
+2.33%
More